r.girard
TL2 · Dijon
Contributes reviews on supplier material. Based in Dijon.
Joined 21 May 2025 · last posted 1d
77 posts, newest first. Showing up to 150.
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #36 · Evidence › Preprints · 27 Jul 2026 · 16 likes Two things can be true about community labels at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is…
-
Common supplements people ask about, assessed one at a time Replied, post #61 · Practice › Interactions · 18 Jul 2026 · 26 likes Post #59 and I disagree about the size of the effect, not about the direction. Timing separation is the standard mitigation where absorption rate is the concern, and…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #42 · Clinical › Prescriber conversations · 16 Jul 2026 · 0 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. I would want to see it done twice before believing it…
-
Restarting after a long gap: what the labelling implies Replied, post #22 · Practice › Dosing & titration · 12 Jul 2026 · 24 likes Answering the question post #20 raises rather than the one it answers. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #70 · Access › International · 10 Jul 2026 · 0 likes Post #69 is the version of this I will quote in future. One addition. A regional experience posted here should say which year it describes. The archive keeps these…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #89 · Devices › Syringes & needles · 29 Jun 2026 · 29 likes Post #85 put the caveat in the right place and I want to underline it. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss…
-
Review: an evidence digest and the citation check that delayed it Replied, post #13 · Documentation › Doc review · 27 Jun 2026 · 25 likes Everything in post #11 holds. The case it does not cover is the one I have. The four criteria are that the question recurs, that the content is correct and sourced or…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #7 · Practice › Dosing & titration · 20 Jun 2026 · 0 likes Right, and stated more narrowly than I would have dared to state it.
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #77 · Practice › Administration · 20 Jun 2026 · 18 likes Coming back to post #73, because the follow-up matters more than the original answer. Pinch or no pinch: the decision depends on needle length and on your own anatomy.…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #8 · marked as the solution · Analytics › Home & field testing · 17 Jun 2026 · 15 likes Consumer-accessible tests would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Five questions in one post gets you one answer — how to split them Replied, post #84 · Start Here › How to Ask · 18 May 2026 · 0 likes Post #80 describes the usual case. This is about the unusual one. Nobody minds being asked to explain a term. The people who use them most are the quickest to define…
-
Semaglutide and alcohol: what is actually documented Replied, post #3 · Compounds › Semaglutide · 11 May 2026 · 14 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #96 · Practice › Interactions · 1 May 2026 · 25 likes Taking post #95 at face value and following it one step further. Where a published interaction study exists it usually reports an area-under-curve ratio, and that…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #33 · Practice › Reconstitution · 19 Apr 2026 · 2 likes This follows post #32 rather than contradicting it. Two people can reconstitute the same vial to different concentrations and both be right. The dose is the same; only…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #6 · Research Methods › N-of-1 designs · 12 Apr 2026 · 28 likes I disagree with the framing of Washout above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked. The…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #55 · Analytics › Mass spectrometry · 4 Apr 2026 · 0 likes On post #51 — agreed on the reasoning, with one qualification. I have been on both sides of the Charge states argument in this category within eighteen months, which…
-
Research-use-only status: what it means legally and practically Replied, post #22 · Compounds › Other compounds · 2 Apr 2026 · 0 likes Adding a data point of agreement rather than a data point.
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #18 · Outcomes › Progress reports · 12 Mar 2026 · 10 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
-
The lowest dose that does anything: is that a real question? Replied, post #91 · Practice › Dosing & titration · 7 Mar 2026 · 28 likes On post #87 — agreed on the reasoning, with one qualification. The version of lowest dose that circulates here is a simplification of a simplification. It is not wrong,…
-
Contributing data without breaching anyone's privacy Replied, post #43 · Data & Tools › Datasets · 5 Mar 2026 · 0 likes On post #39 — agreed on the reasoning, with one qualification. State the inclusion criteria explicitly, including the ones you applied without noticing. "Records I…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #7 · Analytics › Impurities & related substances · 20 Feb 2026 · 0 likes The arithmetic in post #4 is right; the assumption feeding it is the part to check. Aggregates: multiples of the monomer mass. May not elute at all under a standard…
-
Coming back to: Training through a dose escalation week Replied, post #28 · Nutrition & Training › Resistance training · 13 Feb 2026 · 0 likes If you are new and reading this thread for the answer to Training through a dose escalation: the answer is conditional, the conditions are in the third reply, and the…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #28 · Clinical › Special populations · 30 Jan 2026 · 23 likes Body weight at the extremes of the studied range affects exposure and the trials rarely reported enough to say by how much.
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #123 · Clinical › Special populations · 27 Jan 2026 · 15 likes That is the distinction I keep failing to hold on to. Written down now.
-
Foaming during reconstitution and whether it matters — the long version Replied, post #13 · Practice › Reconstitution · 20 Jan 2026 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #47 · Access › International · 9 Jan 2026 · 2 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #17 · Sourcing › Logistics · 5 Jan 2026 · 8 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance.
-
Reused chromatograms across lots: how to spot it Replied, post #11 · Analytics › COA interpretation · 31 Dec 2025 · 11 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Substitution between formats during a shortage Replied, post #114 · Access › Shortages · 12 Dec 2025 · 12 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #24 · Analytics › Impurities & related substances · 3 Dec 2025 · 1 like Fine by me. I had wanted a stronger conclusion and there is not one available.
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #43 · Practice › Reconstitution · 24 Nov 2025 · 11 likes I read post #41 twice before replying, because I had assumed the opposite. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #37 · Clinical › Special populations · 23 Nov 2025 · 29 likes That is the distinction I keep failing to hold on to. Written down now.
-
Guidelines revision: what changed and why — one year on Replied, post #36 · Meta › Announcements · 16 Nov 2025 · 12 likes Narrowing post #33, because the general version has more than one answer. The edit is clearer. For anyone arriving now, read the edited version — the confusion in the…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #93 · Start Here › How to Ask · 13 Nov 2025 · 12 likes Adding the measurement that post #90 says would settle it. "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #2 · Practice › Interactions · 26 Oct 2025 · 10 likes The opening post and I disagree about the size of the effect, not about the direction. Alcohol is not contraindicated in the labelling and it does irritate a stomach…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #108 · Lounge › Off topic · 19 Oct 2025 · 1 like Unserious but true: I can now identify a certificate template at a glance and I have no professional use for that skill whatsoever. That is what the documentation says.…
-
Run-in periods and the population they select Replied, post #10 · Evidence › Trials · 14 Oct 2025 · 22 likes On post #8 — agreed on the reasoning, with one qualification. Something worth flagging about run-in periods: the strongest-sounding claims in this thread are the ones…
-
Compounds this community declines to help with, and why Replied, post #37 · Compounds › Other compounds · 30 Sep 2025 · 19 likes Post #34 answers the question as asked. The question underneath it is different. PT-141 was developed from the same family with a different receptor profile, and it has…
-
What pooling buys you and what it destroys Replied, post #23 · Evidence › Meta-analyses · 16 Sep 2025 · 3 likes I had written a reply contradicting post #20 and deleted it. Here is what survived. Study quality and weighting: some meta-analyses weight all studies equally; others…
-
Injecting into an area that has become firm: why not to — does this still hold? Replied, post #2 · Practice › Administration · 16 Sep 2025 · 13 likes Helpful, and short, which on this subject is harder than long.
-
When a preprint is the best available evidence and we say so Replied, post #153 · Evidence › Preprints · 7 Sep 2025 · 6 likes Adding the measurement that post #152 says would settle it. Preprint sits at the boundary between what this community can usefully discuss and what it cannot, and I…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #101 · Practice › Reconstitution · 7 Aug 2025 · 2 likes Confirming post #98 from a second method, which matters more than confirming it from a second person. Preservative effectiveness is tested against a defined microbial…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #50 · Access › Insurance & coverage · 20 Jul 2025 · 1 like Posting my Reading a denial letter numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #33 · Practice › Reconstitution · 18 Jul 2025 · 0 likes Choose the concentration so that a typical dose lands on a graduation you can actually read. A dose that falls between two marks on a 1 mL barrel is a dose you will get…
-
Coming back to: Why the cheapest option is often not the cheapest Replied, post #25 · Access › Pricing · 25 Jun 2025 · 2 likes Marking my uncertainty on cheapest option explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #74 · Practice › Reconstitution · 22 Jun 2025 · 3 likes Everything in post #73 holds. The case it does not cover is the one I have. The question underneath 10 mg vial reconstituted three is usually "how would I tell?" rather…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #79 · Compounds › Cagrilintide & amylin analogues · 12 Jun 2025 · 3 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #60 · Nutrition & Training › Protein & intake · 11 Jun 2025 · 12 likes Tracking intake is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Insulin combinations and hypoglycaemia risk Replied, post #3 · Practice › Interactions · 8 Jun 2025 · 2 likes This follows the opening post rather than contradicting it. Where the insulin combinations and hypoglycaemia risk discussion usually stalls is that nobody wants to say…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #7 · marked as the solution · Nutrition & Training › Protein & intake · 2 Jun 2025 · 29 likes I read post #5 twice before replying, because I had assumed the opposite. The version of Tracking intake that I was taught turned out to be a teaching simplification.…
-
A ten-fold dose error caught before injection Replied, post #43 · Devices › Syringes & needles · 2 Jun 2025 · 1 like I had written a reply contradicting post #41 and deleted it. Here is what survived. Reusing a needle blunts it and there is no benefit to offset that. The second…
-
Lipase elevation without symptoms: the interpretation problem — a second dataset Replied, post #7 · Clinical › Bloodwork · 31 May 2025 · 5 likes Narrowing post #4, because the general version has more than one answer. Reading this Lipase elevation without symptoms thread as someone who came in with a fixed view:…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #24 · Evidence › Journal club · 30 May 2025 · 0 likes I read the earlier replies on STEP 4 twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather…
-
Metformin co-administration and additive GI effects Replied, post #29 · Practice › Interactions · 2 May 2025 · 16 likes The practical version of metformin co-administration is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
-
Certificates issued by the seller versus by a laboratory Replied, post #34 · Analytics › COA interpretation · 7 Apr 2025 · 5 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Started this topic · Practice › Interactions · 22 Feb 2025 · 17 likes On the subject in the title: Delayed gastric emptying and oral medication absorption: which drugs matter Working notes rather than a conclusion. A follow-up question…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #60 · Evidence › Meta-analyses · 5 Feb 2025 · 2 likes Bookmarking this. I will come back when I have something worth adding.
-
Coming back to: An 18-month record including the parts that went badly Replied, post #14 · Outcomes › Progress reports · 5 Feb 2025 · 2 likes Bookmarking this. I will come back when I have something worth adding.
-
Talking to a therapist about this specifically — does this still hold? Replied, post #7 · Wellbeing › Mental health · 19 Jan 2025 · 11 likes Where a member is finding this hard, the useful reply is usually a question rather than an answer, and this subcategory does that well. Old habit: I write down the…
-
Escalating every six weeks instead of four: what I observed over eight months Replied, post #21 · Practice › Dosing & titration · 15 Jan 2025 · 16 likes Post #18 describes the usual case. This is about the unusual one. The four-week step is a trial convention, not a pharmacological constant. It is roughly four…
-
Recovery when intake is low: what to cut first Replied, post #25 · Nutrition & Training › Resistance training · 10 Jan 2025 · 0 likes Post #21 and I disagree about the size of the effect, not about the direction. Practical note on recovery: write down what you expect before you look. The number of…
-
Body image changing more slowly than the body Replied, post #104 · Wellbeing › Mental health · 22 Dec 2024 · 11 likes Everything in post #100 holds. The case it does not cover is the one I have. Body image: I would want to see the raw numbers rather than the summary before agreeing.…
-
Fixed versus detachable needles: the trade-offs Replied, post #47 · Devices › Syringes & needles · 13 Dec 2024 · 18 likes Fixed versus detachable needles came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #25 · Wellbeing › Mental health · 9 Dec 2024 · 13 likes Tracking mood alongside dose and weeks, on a simple scale, produces a record that is far more useful than a recollection at an appointment. If anyone can point at the…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #17 · Devices › Cold chain · 3 Dec 2024 · 29 likes The arithmetic in post #16 is right; the assumption feeding it is the part to check. Repacking cold material into a domestic refrigerator promptly on arrival is the one…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #112 · Compounds › Repair & healing peptides · 21 Nov 2024 · 0 likes Dose-response is unstudied in humans for essentially everything in this family, which means the confident numbers in circulation came from somewhere other than a trial.
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #39 · Compounds › Tirzepatide · 22 Oct 2024 · 22 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #125 · Access › Shortages · 13 Oct 2024 · 0 likes Regional differences during a shortage are large, and a supply position in one country says nothing about another. It reads as pedantry until the day it does not.
-
Follow-up: Trifluoroacetate content and its consequences Replied, post #5 · Analytics › Impurities & related substances · 12 Oct 2024 · 0 likes Where an impurity is identified rather than merely counted, the certificate is telling you the manufacturer has characterised its own process. That is a meaningful…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #58 · Access › Shortages · 11 Oct 2024 · 3 likes Where I part company with post #56, and it is a narrow parting. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #27 · Compounds › Retatrutide · 9 Sep 2024 · 0 likes Post #26 is right about the mechanism and I think understates the practical bit. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison…
-
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #6 · Compounds › Oral incretins · 26 Aug 2024 · 18 likes Post #4 describes the usual case. This is about the unusual one. On identity for a small molecule: a mass match plus a retention-time match against an authentic…
-
Circumference measurements as a poor man's composition estimate Replied, post #92 · Outcomes › Body composition · 23 Aug 2024 · 0 likes Speaking only to circumference measurements as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread…
-
Circumference measurements as a poor man's composition estimate Replied, post #71 · Outcomes › Body composition · 16 Aug 2024 · 1 like Helpful, and short, which on this subject is harder than long.
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Started this topic · Practice › Side effects · 23 Jun 2024 · 47 likes Posting this under the heading it deserves: The nausea timeline across the first four weeks, with a tabulated log Everything below is what sits behind that. Reading…
-
Assessing a warm arrival: the decision process — one year on Replied, post #13 · Sourcing › Logistics · 28 May 2024 · 29 likes Right, and stated more narrowly than I would have dared to state it.
-
Two sessions a week versus four: what the evidence supports — a second dataset Started this topic · Nutrition & Training › Resistance training · 26 May 2024 · 7 likes Two sessions a week versus four: what the evidence supports — a second dataset — setting out what I have, and where I think it stops being reliable. Reporting rather…